Winning approval to target the 15,000 U.S. patients with locally advanced pancreatic cancer is the first step in a broader expansion in the tumor type.
GALWAY, Ireland, Feb. 13, 2026 /PRNewswire/ — InVera Medical, an Irish medical technology company, has received European regulatory approval for a new minimally invasive device designed to help physicians deliver treatment more effectively to diseased leg veins, including varicose veins.
TAICHUNG, Feb. 13, 2026 /PRNewswire/ — Cancer has long ranked among the leading causes of death in Taiwan, and solid tumors account for more than 90% of cancer cases worldwide—making them the most challenging frontier for CAR-T cell therapy. China Medical University Hospital (CMUH) announced today that, in collaboration with Ever Supreme Bio Technology, it has successfully developed the world’s first EXO 001 targeted exosome platform, a breakthrough technology that enables direct in vivo programming of T cells to generate multi-target nanobody-based CAR-T cells.
New techniques to detect Y chromosome genes show frequent loss of the Y in tissues of older men.
Encora Therapeutics announced today that it received FDA 510(k) clearance for its Encora X1 device.
Novocure (Nasdaq:NVCR) announced that the FDA granted approval for its Optune Pax treatment for advanced pancreatic cancer.
A multidisciplinary study led by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) and published in Circulation Research provides a new perspective on why this arrhythmia can persist long-term, highlighting the key role of non-contractile cardiac cells.
A new MRI technique called Velocity Spectrum Imaging can map fluid movement in the human brain within a 3D pixel.
With a new MRI technique that shows both heart tissue and blood flow simultaneously, physicians can see where heart defects occur and precisely plan to repair them, according to new research.
An international research team has gained new insights into the dynamics of myelin swellings in the brain.